Top Story

Universal stool donor model for FMT improves screening, reduces costs, delays

May 22, 2015

Study data show the need for evidence-based stool screening standards, and the usefulness of the universal donor model for fecal microbiota transplantation therapy for recurrent Clostridium difficile infection, according to a distinguished abstract presented at Digestive Disease Week.

“Where do we find these supremely healthy donors, and how do we know who is eligible to be a fecal transplant donor?” Laura J. Burns, from OpenBiome, an international public stool bank in Medford, Massachusetts, said in her presentation. “We have a three-step approach to recruiting and determining the eligibility of our donors.”

FDA News

FDA seeks more data on antimicrobial sales for food-producing animals

May 22, 2015
To obtain a clearer picture of antimicrobial use in food-producing animals in the United States, the FDA has proposed a rule that would require animal drug sponsors to…

Foundation aims to assist HCV patients with therapy costs

May 22, 2015
The HealthWell Foundation announced the launch of a new fund aimed to assist people living with hepatitis C virus infection who are underinsured, according to a news…
In the Journals

California prison workers at increased risk for coccidioidomycosis

May 22, 2015
The average annual incidence of coccidioidomycosis among prison employees at two California prisons appeared higher than that of the general population in surrounding…
In the Journals

Rotavirus vaccination significantly impacts seizure-related hospitalizations

May 22, 2015
Rotavirus vaccination significantly decreased seizure-related hospitalizations during childhood, which appeared to be highest among the youngest group of infants during…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

April 25, 2015
VIENNA — Howard Monsour Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of…
More »
CME
Infectious Disease Case Consults

The Patient with Hepatitis C

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with hepatitis C.
More »
morganatic-roan